Story thread · 2 reports / 2 sources
Royalty Pharma (RPRX): Can Downside Protection Offset Pelacarsen’s Phase 3 Failure?
finance.yahoo.com · 4d
First report: Uranium Royalty Corp: royalty model, strong cash flow, but valuation implies downside — investing.com, 5d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.